Pelthos Therapeutics Inc.
PTHS
$37.00
$2.256.48%
AMEX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -94.68% | 23.21% | 52.30% | -19.20% | -85.84% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -84.45% | 194.77% | -95.30% | -100.00% |
| Total Other Non-Cash Items | -9.91% | 66.03% | -83.52% | -28.70% | 1.26% |
| Change in Net Operating Assets | 247.80% | 330.52% | 19.49% | 85.54% | -667.60% |
| Cash from Operations | 84.86% | 68.27% | -87.86% | 30.83% | -1,425.00% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -76.37% | -- | -187.89% | -552.95% | 599.56% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -67.66% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -76.37% | -95.59% | -116.54% | -590.81% | 599.56% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 94.72% | -110.40% | -1,107.47% | -1,846.19% | -4,199.40% |